PALO ALTO, Calif. -- March 8, 1999 -- Varian Associates, Inc., today announced that it has filed Form 10 registration statements for its instruments and semiconductor spin-off businesses and an 8-K report for its remaining health care systems business with the Securities and Exchange Commission (SEC).
The company said the filings include information statements which provide expanded individual financial results for the three businesses for the first quarter of fiscal 1999. The filings are available through the SEC's Electronic Data Gathering Analysis and Retrieval system (EDGAR).
As reported in previous announcements, the company's shareholders and board of directors have approved the spin-off of the instruments and semiconductor equipment operations as independent, public companies and the renaming of the remaining entity as Varian Medical Systems. The distribution of shares is scheduled to take place April 2, 1999 to shareholders of record March 24, 1999.
Varian is the world's leading manufacturer of medical accelerators and related radiotherapy products for the treatment of cancer. Over 100,000 cancer patients are helped each day on Varian equipment. Varian's products include the Clinac® family of medical linear accelerators, VariSource™ brachytherapy systems, Ximatron® simulators, CADPlan computerized treatment planning systems, and the VARiS® information system. More than 3,500 Varian systems are in place around the world, treating over a million patients each year. Varian is also the world's largest manufacturer of X-ray tubes used in CT scanners and mammography and other medical imaging systems.
FOR INFORMATION CONTACT:
Christine Oliver, Varian Medical Systems
+1 (650) 424-5033
christine.oliver@os.varian.com